Chinese medicinal composition for treating hepatofibrosis

A composition and fibrosis technology, applied in the directions of drug combination, digestive system, pharmaceutical formula, etc., can solve the problems of high morbidity, difficult to determine curative effect, high toxicity and so on

Inactive Publication Date: 2013-04-03
HUANGHUAI UNIV
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In view of the high incidence of liver cirrhosis, there is no ideal effective drug treatment for liver fibrosis, the toxicity of western medicine is relatively high, and the curative effect is not easy to determ...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese medicinal composition for treating hepatofibrosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] The present invention will be described in detail below in conjunction with specific embodiments.

[0008] The traditional Chinese medicine composition for the treatment of liver cirrhosis and fibrosis, i.e. Loach Biejia powder (pills, decoction) medicinal composition: 10-20 g of turtle shell, 10-20 g of tortoise shell, 9-15 g of curcuma, 12-15 g of trigonium, black Sesame 18-25 g, Ligustrum lucidum 15-18 g, loach dry powder 30 g.

[0009] Addition and subtraction according to the syndrome: type Ⅰ (type Ⅰ, type Ⅱ, and type Ⅲ, refer to the following TCM syndrome differentiation content) plus 6-12g of Fructus aurantium, 10 g of Jiao Sanxian, Jiaomaiya, Jiao Hawthorn, and Jiao Shenqu, jaundice caused by damp heat Add 12-18 g of Capillaris, 10-15 g of Gardenia; 20-30 g of Dandelion, 6-9 g of Panax notoginseng, 6-9 g of Radix Paeoniae Rubra, 8-12 g of Curcuma japonica, for those with bleeding tendency Add Agrimony 6-9 g, Eclipta 9-12 g; Type Ⅲ add Codonopsis 12-18 g, Cornus...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Chinese medicinal composition for treating hepatofibrosis, which is mainly prepared from the following main raw materials: 10-20g of trionyx sinensis shell, 10-20g of tortoise shell, 9-15g of curcuma zedoary, 12-15g of rhizoma sparganii, 18-25g of black sesame seeds, 15-18g of glossy privet fruit and 30g of dry loach powder. The following raw materials of the Chinese medicinal composition can be added selectively to treat the I-type symptoms of hepatofibrosis: 6-12g of fructus aurantii, 10g of coked malt, 10g of coked hawthorn, 10g of coked medicated leaven, and in addition, 12-18g of oriental wormwood and 10-15g of cape jasmine can be added to treat internal dampness and heat and jaundice. The following raw materials of the Chinese medicinal composition can be added selectively to treat the II-type symptoms of hepatofibrosis: 20-30g of dandelion, 6-9g of pseudo-ginseng, 6-9g of red peony root, 8-12g of curcuma aromatica, and in addition, 6-9g of hairyvein agrimony and 9-12g of eclipta alba can be added to treat hemorrhage. The following raw materials of the Chinese medicinal composition can be added selectively to treat the III-type symptoms of hepatofibrosis: 12-18g of codonopsis pilosula, 8-10g of dogwood and 9-12g of caulis spatholobi. 9-15g of subprostrate sophora and 1.5g of cordyceps sinensis can be added and decocted together with the raw materials to treat the positive marker of hepatitis B virus. The Chinese medicinal composition has a significant effect on 502 patients (69.05%) of the total 727 patients with the hepatofibrosis, is effective to 189 patients (26.00%), and is invalid to 36 patients (4.95%), thereby having the total effective rate of 95.05%.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine for treating liver cirrhosis, in particular to a traditional Chinese medicine composition for treating liver cirrhosis and fibrosis. Background technique [0002] Once viral hepatitis develops liver cirrhosis, firstly, the rate of canceration will increase significantly, and about 1 million liver cancers will occur every year; secondly, Western medicine and western medicine basically have no systematic and effective measures and methods, which seriously threaten human health. Therefore, the state allocates huge sums of money every year to support research on the prevention, diagnosis, treatment, and drug development of liver cirrhosis and even viral hepatitis, and conducts regular academic exchanges and discussions. It is designed to conquer demons that threaten human health in a relatively short period of time. The main lesion of liver cirrhosis is the formation of pseudolobules, and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/9066A61P1/16
Inventor 张小兆宋新勤吴伟罗焕新李蓓蓓
Owner HUANGHUAI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap